Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
40 hedge funds and large institutions have $132M invested in Longevity Health Holdings, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
17% more capital invested
Capital invested by funds: $113M → $132M (+$19.1M)
5% more funds holding
Funds holding: 38 → 40 (+2)
0.34% more ownership
Funds ownership: 2.39% → 2.73% (+0.34%)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$14.9M |
| 2 |
JP Morgan Chase
New York
|
+$11.2M |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.78M |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.51M |
| 5 |
CIM
Cowen Investment Management
New York
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$14.6M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.05M |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$882K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$167K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$167K |
XAGE Hedge Fund Activity: Q1 2023 in Review
40 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q1 2023, worth a combined $132M — up 17% from $113M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new XAGE positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $14.9M. The largest seller was Sculptor Capital, exiting entirely with an estimated $14.6M sold.
- 40 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q1 2023, up from 38 in Q4 2022.
- Funds reported $132M of Longevity Health Holdings, Inc. Common Stock stock for Q1 2023, up 17% quarter-over-quarter.
- 7 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q1 2023 and 5 closed out, a net change of +2 holders.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q1 2023 was UBS O'Connor, an estimated $14.9M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q1 2023 was Sculptor Capital, an estimated $14.6M sold.
Based on aggregated 13F filings for Q1 2023.